Related Experiment Videos

Natural and designer binding sites made by phage display technology

H R Hoogenboom1, P Chames

  • 1Target Quest BV, a subsidiary of Dyax Corp, PO Box 5800, 6202 AZ Maastricht, The Netherlands. hhoogenboom@targetquest.nl

Immunology Today
|August 1, 2000
PubMed
Summary

Phage display technology enables the creation of high-affinity, fully human antibodies for therapeutic use. This review highlights its applications in antibody engineering and development.

Related Concept Videos